Thrombolex Inc.

Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters.

10/26/2025

Today at TCT 2025, join Dr. Wissam Jaber at 12:04 pm in Innovation Session 3: Innovations in Endovascular and Pulmonary Embolism Treatment, as he presents an interim data analysis of the RAPID-PE Study. Results show that on-the-table pharmaco-mechanical lysis (PML) with the BASHIR™ Endovascular Catheter delivers efficient and safe PE therapy that reduces the need for ICU infusion and supports improved patient outcomes.
Thrombolex.com

10/22/2025

In this clip, Dr. Ayman Iskander discusses how the BASHIR™ Endovascular Catheter enhances clinical impact by restoring blood flow quickly and safely, helping patients recover quickly while optimizing hospital resources.

Thrombolex.com

10/20/2025

As TCT 2025 approaches, we invite you to join us for the RAPID-PE Study interim data analysis presented by Dr. Wissam Jaber on Sunday, October 26 at 12:04 pm during Innovation Session 3. This analysis underscores how pharmaco-mechanical lysis (PML) with the BASHIR™ Endovascular Catheter can streamline acute PE therapy by providing efficient and safe treatment that helps avoid the need for post-procedural ICU infusion while supporting improved patient outcomes. Thrombolex is committed to advancing vascular intervention through innovation, collaboration, and solutions that prioritize patient safety.
Thrombolex.com

10/17/2025

Join Thrombolex during TCT 2025 on October 26 as Dr. Wissam Jaber presents an interim data analysis of the RAPID-PE Study. This analysis highlights how on-the-table pharmaco-mechanical lysis (PML) with the BASHIR™ Endovascular Catheter can safely reduce right heart strain, avoid ICU infusions, and support improved outcomes in acute PE care.

Thrombolex.com

10/13/2025

Today is World Thrombosis Day. Thrombolex reaffirms our commitment to raising awareness about the serious impact of blood clots. Our focus remains on providing safe, effective Endovascular Catheter solutions for the treatment of thromboembolic disease. Learn more at www.worldthrombosisday.org.

Thrombolex.com

10/10/2025

Methodist Stone Oak Hospital in San Antonio has successfully performed its first pulmonary embolism (PE) case using the BASHIR™ Endovascular Catheter, becoming the first HCA hospital nationwide to adopt this innovative therapy. We’re proud to support Methodist Stone Oak and HCA Healthcare in advancing patient care with the BASHIR™ Endovascular Catheter. Congratulations to Dr. Liu and the team at Methodist Stone Oak for completing the hospital's first PE case with the BASHIR™ Endovascular Catheter.

09/30/2025

Innovation starts with design. The BASHIR™ Endovascular Catheter is engineered to enhance precision and efficacy in the treatment of acute PE, while minimizing complications. Its dual-action expandable infusion basket mechanically fissures the thrombus while delivering targeted thrombolytic therapy. This combined therapy promotes immediate clot resolution.

Thrombolex.com

09/29/2025

Hospital economics are a key factor in acute PE care. In this video, Dr. Wissam Jaber explains how the on-the-table protocol with the BASHIR™ Endovascular Catheter can help lower total care costs by reducing ICU stays and streamlining workflow.

Thrombolex.com

09/26/2025

Thank you to PERT 2025 for an inspiring event. Thrombolex is proud to contribute to the advancement of pulmonary embolism treatment and grateful for the chance to connect with leaders in the field, share insights, and help shape the future of patient care.

Thrombolex.com

09/22/2025

At Thrombolex, we define innovation by its impact on patient care. For those with acute PE, that means advancing therapies that lead to efficient therapy delivery, less medication, and improved clinical outcomes.

Less time. Lower dose. Better Outcomes.

Thrombolex.com

09/17/2025

PERT 2025 begins today. Visit Thrombolex at booth 300 or attend our Breakfast Satellite Session September 18th to learn how single-session, low-dose pharmaco-mechanical lysis (PML) with the BASHIR™ Endovascular Catheter is advancing the treatment of acute PE. This approach improves patient outcomes while supporting the health system's efficiency.

Thrombolex.com

09/14/2025

This week, join us for an insightful Breakfast Satellite Session during PERT 2025 where Dr. Ken Rosenfield, Dr. Vivian Bishay, Dr. Wissam Jaber, and Dr. Soophia Naydenov will examine how a breakthrough on-the-table PE therapy is re-writing the health economics story.

Thrombolex.com

Address

75 Britain Drive
New Britain, PA
18901

Telephone

+18447926300

Website

http://www.thrombolex.com/

Alerts

Be the first to know and let us send you an email when Thrombolex Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Thrombolex Inc.:

Shortcuts

Want your practice to be the top-listed Clinic in New Britain?